p-Index From 2020 - 2025
0.408
P-Index
This Author published in this journals
All Journal MEDICINUS
Claim Missing Document
Check
Articles

Found 2 Documents
Search

Granulomatosis Wegener dengan Antineutrophil Cytoplasmic Antibodies (ANCA) Negatif pada Laki-laki Usia 38 Tahun Achmad Satya Negara; Harijono Kariosentono; Endra Yustin Elistasari
MEDICINUS Vol. 34 No. 2 (2021): MEDICINUS
Publisher : PT Dexa Medica

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (313.981 KB) | DOI: 10.56951/medicinus.v34i2.72

Abstract

Background : Wegener’s granulomatosis or granulomatosis with polyangiitis is a systemic necrotizing vasculitis, which affects small- and medium-sized blood vessels. This disease is often associated with antineutrophil cytoplasmic antibodies (ANCA). Etiology of Wegener’s granulomatosis may originate from infectious, environmental, chemical, toxic or pharmacological triggers in people who are genetically predisposed to this autoimmune disease. The disease can present with nonspecific symptoms such as malaise, myalgia, arthralgia, anorexia, and weight loss. Skin manifestations of Wegener’s granulomatosis includes leukocytoclastic vasculitis, purpura, ulcer and subcutaneus nodul. It also known could affect different organs. Case: A 38-year-old man came with a chief complaint of erythematous patches and stiffness on his face, body, arms and legs. The dermatological status showed a saddle nose and discrete multiple purpura on the superior and inferior extremities. ANCA examination result was negative. Histopathological examination of the epidermal layer showed dense proliferation of lymphocyte cells, perivascular infiltrates and a few neutrophil cells. In the dermis layer, there were granulomas consisting of many epitheloid histiocytes and foamy macrophages also damaged blood vessels with neutrophil infiltration on the walls and erythrocyte extravasation. Discussion: Wegener’s granulomatosis is a rare autoimmune disease of localized granulomatous inflammation of the upper and lower respiratory tract and systemic vasculitis associated with ANCA. Symptoms that arise in Wegener’s granulomatosis are often mild at first, but may progress to a more severe clinical features. A negative ANCA examination cannot immediately rule out the diagnosis. Initial therapy for Wegener’s granulomatosis are cyclophosphamide and glucocorticoids for 3-6 months. Patient showed clinical improvement with the reduction of purpura throughout the body after five weeks treatment.
Familial Erythema Annulare Centrifugum pada Anak Berusia 9 Tahun Achmad Satya Negara; Endra Yustin Elistasari
MEDICINUS Vol. 34 No. 3 (2021): MEDICINUS
Publisher : PT Dexa Medica

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (254.845 KB) | DOI: 10.56951/medicinus.v34i3.80

Abstract

Background: Erythema annulare centrifugum (EAC) is a rare cutaneous disease characterized by erythematous papule which slowly migrates and peripherally enlarges into polycyclic lesion with central clearing that usually involves thigh and legs area. The etiology is unclear, but presumabley related with medication history, infection, malignancy, and stress. The diagnosis of EAC is based on clinical manifestations and histopathological examination. Histopathologically, EAC can be divided into superficial and deep type. Pathognomonic signs include coat sleeve and trailing scale. Symptomatic treatment of EAC may involve topical corticosteroid, topical vitamin D analog, and antihistamine. Case: A 9-year-old boy came with a complaint of erythematous patches on his face and body. Histopathological biopsy showed showed a mild appearance of hyperkeratosis and spongiosis at the epidermis, and perivascular lymphocytic infiltrate at the dermis. Based on these findings, patient was diagnosed with erythema annulare centrifugum. We gave antihistamine and topical corticosteroid to treat his condition. Discussion: Erythema annular centrifugum is a rare skin condition, with most cases is idiopathic. Histopathological biopsy can be used to help establish the diagnosis of EAC. Topical & systemic corticosteroid is the first-line therapy of idiopathic EAC, but administration of empirical therapy using antibiotics or antifungals may also be considered.